ANZEMET (Validus Pharmaceuticals LLC)
Welcome to the PulseAid listing for the ANZEMET drug offered from Validus Pharmaceuticals LLC. This Serotonin 3 Receptor Antagonists [MoA],Serotonin-3 Receptor Antagonist [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Validus Pharmaceuticals LLC |
NON-PROPRIETARY NAME: | dolasetron mesylate |
SUBSTANCE NAME: | DOLASETRON MESYLATE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Serotonin 3 Receptor Antagonists [MoA],Serotonin-3 Receptor Antagonist [EPC] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET, FILM COATED |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 1997-09-11 |
END MARKETING DATE: | 0000-00-00 |
ANZEMET HUMAN PRESCRIPTION DRUG Details:
Item Description | ANZEMET from Validus Pharmaceuticals LLC |
LABELER NAME: | Validus Pharmaceuticals LLC |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 50(mg/1) |
START MARKETING DATE: | 1997-09-11 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 30698-120_290c93ea-741e-4fe8-bf2a-7da24ee1aa87 |
PRODUCT NDC: | 30698-120 |
APPLICATION NUMBER: | NDA020623 |
Other DOLASETRON MESYLATE Pharmaceutical Manufacturers / Labelers: